The Accidental Dental Strategist
Why the European dental market needs a country-by-country strategy, not a continental one
By Andy Sloan
· Updated 28 September 2026 · 2 min read
Stop treating "the European dental market" as one story.
It isn't. It's seven different stories wearing the same trade press headline, and the version that gets told most often, private equity rolling up fragmented practices, only actually describes about half of them properly.
In the UK, the pressure is a state funding failure. NHS dentistry is being squeezed by a contract that redistributes an unchanged budget rather than growing it, and that is what is pushing the private shift, not consolidation appetite.
In Germany, the constraint is legal, not commercial. Private investors still cannot hold shares in a dental MVZ directly, which is exactly why German platforms have changed hands between funds more than once. If you are a supplier who thinks you have won a German account, check who owns it before you plan next year's revenue.
In Italy and the Nordics, the real story is procurement leverage. The largest regional platforms are negotiating volume agreements directly with implant manufacturers now, not just buying more units. That is a different kind of scale to the one most people mean when they say consolidation.
In Spain and France, trust is the currency. A high-profile collapse in Spain, and a wave of low-cost centre scandals in France, mean patient financial protection now sells as a genuine differentiator in those two markets and would be a wasted pitch anywhere else.
And Poland is not running the same game at all. Dental there is a module bolted onto a private health membership, led by insurers, not private equity. Pitch a dental-only platform into that market and you are answering a question nobody asked.
The lesson for anyone building a pan-European strategy, whether you are a DSO, a manufacturer, or a software supplier, is the same one people keep learning the hard way. "One platform, many flags" is a much harder promise to keep than it sounds, because the thing that varies country to country is not language or branding. It is who is allowed to own the business, who controls the money, and what the market has already been burned by.
DSO / provider lens
| Theme | UK | Germany | France | Spain | Italy | Nordics | Poland/CEE |
|---|---|---|---|---|---|---|---|
| Payer squeeze forcing private shift | High | Low | High | Med | Low | Low | Low |
| Trust and quality scars from past failures | Low | Low | High | High | Low | Low | Low |
| Insurer-led, not PE-led, consolidation logic | – | – | Low | – | – | – | High |
| Ownership-structure regulatory friction | Low | High | Low | Low | Low | Low | Low |
| Capital patience of controlling shareholder | Med | Low | Med | Low | Low | High | – |
Supplier / manufacturer lens
| Theme | UK | Germany | France | Spain | Italy | Nordics | Poland/CEE |
|---|---|---|---|---|---|---|---|
| Buyer procurement power (volume tenders) | Med | Med | Low | Med | High | High | – |
| Need for country-specific product, not portable core | Med | High | High | Med | Med | Low | High |
| Re-tender / ownership-churn risk to contracts | Med | High | Low | Med | Med | Low | – |
| Trust infrastructure as a sellable differentiator | Low | Low | High | High | Low | Low | Low |
| Must sell as a module inside a bigger platform, not standalone | Low | Low | Low | Low | Low | Low | High |
Next read: The three prices of a dental business →